Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer
Dr Etienne Brain - Institut Curie, Paris, France
Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer ( Dr Etienne Brain - Institut Curie, Paris, France )
6 Jun 2022
COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity i...
Dr Sumanta K. Pal - City of Hope Comprehensive Cancer Center, Duarte, USA
COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity in inoperable locally advanced/metastatic urothelial carcinoma ( Dr Sumanta K. Pal - City of Hope Comprehensive Cancer Center, Duarte, USA )
5 Jun 2022
Safety follow-up of the randomized, phase 3 study DESTINY-Breast03
Dr Erika Hamilton - Sarah Cannon Research Institute, Tennessee, USA
Safety follow-up of the randomized, phase 3 study DESTINY-Breast03 ( Dr Erika Hamilton - Sarah Cannon Research Institute, Tennessee, USA )
5 Jun 2022
Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-defic...
Dr Andrea Cercek - Memorial Sloan Kettering Cancer Centre, Manhattan, New York
Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient locally advanced rectal cancer ( Dr Andrea Cercek - Memorial Sloan Kettering Cancer Centre, Manhattan, New York )
5 Jun 2022
Circulating tumour DNA analysis can help identify the need for adjuvant therapy ...
Dr Jeanne Tie - The Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer ( Dr Jeanne Tie - The Peter MacCallum Cancer Centre, Melbourne, Australia )
4 Jun 2022
Circulating tumour DNA analysis can help identify the need for adjuvant therapy ...
Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )
4 Jun 2022
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC
Dr Roy Herbst - Yale Cancer Center, New Haven, USA
Ramucirumab plus pembrolizumab improves OS in advanced NSCLC ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
4 Jun 2022
Cancer Services Delivery: Focus on India
Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Cancer Services Delivery: Focus on India ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
26 May 2022
Pre-operative risk factors associated with peri-operative psychiatric diagnosis ...
Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India
Pre-operative risk factors associated with peri-operative psychiatric diagnosis in oral cancer patients ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )
25 May 2022
The role of the Global Coalition for Radiotherapy in the war in Ukraine
Dr Ruslan Zelinskyi, Prof Patricia Price
The role of the Global Coalition for Radiotherapy in the war in Ukraine ( Dr Ruslan Zelinskyi, Prof Patricia Price )
25 May 2022
War in Ukraine: The pyscho-oncology perspective
Prof Csaba Dégi - SEO, International Psycho-Oncology Society
War in Ukraine: The pyscho-oncology perspective ( Prof Csaba Dégi - SEO, International Psycho-Oncology Society )
5 May 2022
War in Ukraine: Impacts on the Polish cancer care system and vaccination challen...
Prof Piotr Rutkowski - National Research Institute of Oncology, Warsaw, Poland
War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges ( Prof Piotr Rutkowski - National Research Institute of Oncology, Warsaw, Poland )
4 May 2022